Latest Organofluorides Stories
-- Nexavar is the only approved treatment for patients with RAI-refractory differentiated thyroid cancer -- Nexavar significantly extended progression-free survival
The Firm is representing a number of Risperdal lawsuit clients in the Pennsylvania litigation who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic
Tokyo, July 3, 2014 - (JCN Newswire) - Eisai Co., Ltd.
Despite strong preclinical data, the drug everolimus failed to improve overall survival in patients with advanced liver cancer, compared to placebo.
LONDON, July 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, June 30, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
SAN ANTONIO, June 30, 2014 /PRNewswire/ -- GenSpera, Inc.
GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs.
The Firm is representing a number of men and boys in Risperdal lawsuits that claim use of the atypical antipsychotic medication caused gynecomastia (male breast growth). New
The Firm represents Risperdal lawsuit clients in claims that allege the antipsychotic medication caused men and boys to develop gynecomastia. Rockville Centre,
- Inward knowledge; understanding; conscience.